Patient Experience
My 8-year-old son had a mysterious, persistent swelling in his neck that baffled several pediatricians. We were referred to Prof. Dr. Yapicier for a biopsy analysis. What struck me was her direct call to us after the procedure. She didn't just send a report; she explained the rare 'Kikuchi-Fujimoto disease' diagnosis in terms we could grasp, drew diagrams on a notepad over the phone to show the lymph node architecture, and coordinated personally with our pediatrician for a non-alarming, watchful waiting plan. Her voice was calm but carried immense authority. The pathology wasn't just a slide to her; it was the key to my child's anxiety-free recovery. We never met her in person, but her clarity turned a terrifying unknown into a manageable condition.
As a 72-year-old with a complex history of prostate cancer, my latest PSA spike led to a new biopsy. The urologist sent the samples to Prof. Dr. Ozlem Yapicier. Days later, I was in her office, a rarity, I'm told, for a pathologist. She had my slides on a large screen and previous biopsies from five years ago for comparison. She pointed out minute cellular changes, explaining why this represented a very low-grade recurrence, not aggressive spread. 'Your cancer is taking a leisurely walk, not a sprint,' she said. Her meticulous side-by-side analysis prevented me from undergoing immediate, harsh therapy. Her review felt like a deep historical investigation of my own body, providing not just a diagnosis but a strategic forecast.
It was a Friday evening emergency. My wife, 34, had an appendectomy, but the surgeon found unusual peritoneal deposits. The tissue was rushed to pathology. Prof. Dr. Yapicier was consulted. She didn't wait for morning. She performed a frozen section analysis intraoperatively and diagnosed pseudomyxoma peritonei, a rare, mucinous condition. She then came to the OR viewing room to brief the surgical team and, through them, me. Her decisive input changed the entire surgical plan on the spot to a more extensive cytoreductive procedure. Her work in those night hours wasn't about identifying cells; it was about real-time, high-stakes cartography of disease, directly shaping the surgery happening concurrently. Her report read like an urgent battlefield dispatch that guided the surgeons' hands.
I was a routine colonoscopy case, a 45-year-old with no symptoms. A single, small polyp was removed. The standard report came back, but with an addendum note personally signed by Prof. Dr. Yapicier. She had identified a focal area of 'serrated architecture' that could be missed, recommending a shortened, 3-year follow-up instead of the usual 10 years. She took initiative on what others might have called a normal polyp. It felt like having a master proofreader check a vital document. There was no drama, no patient interaction, yet her silent, expert vigilance in the background potentially altered the trajectory of my preventive health for a decade. It was preventive pathology at its finest, a guard catching a subtle signal in complete silence.